In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)Carlotta Ranieri, Nicoletta Resta|Neurogenetics|2018Cited by 83